GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SCM Lifescience Co Ltd (XKRX:298060) » Definitions » Gross-Profit-to-Asset %

SCM Lifescience Co (XKRX:298060) Gross-Profit-to-Asset % : 3.09% (As of Mar. 2025)


View and export this data going back to 2020. Start your Free Trial

What is SCM Lifescience Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. SCM Lifescience Co's annualized Gross Profit for the quarter that ended in Mar. 2025 was ₩811 Mil. SCM Lifescience Co's average Total Assets over the quarter that ended in Mar. 2025 was ₩26,262 Mil. Therefore, SCM Lifescience Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 3.09%.


SCM Lifescience Co Gross-Profit-to-Asset % Historical Data

The historical data trend for SCM Lifescience Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SCM Lifescience Co Gross-Profit-to-Asset % Chart

SCM Lifescience Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.47 0.53 0.40 1.16 1.34

SCM Lifescience Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.83 1.15 1.89 1.19 3.09

Competitive Comparison of SCM Lifescience Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, SCM Lifescience Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SCM Lifescience Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SCM Lifescience Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where SCM Lifescience Co's Gross-Profit-to-Asset % falls into.


;
;

SCM Lifescience Co Gross-Profit-to-Asset % Calculation

SCM Lifescience Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=326.501/( (25403.788+23169.708)/ 2 )
=326.501/24286.748
=1.34 %

SCM Lifescience Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=810.692/( (23169.708+29354.619)/ 2 )
=810.692/26262.1635
=3.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


SCM Lifescience Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of SCM Lifescience Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


SCM Lifescience Co Business Description

Traded in Other Exchanges
N/A
Address
366, 310 Seohae-daero, Jung-gu, Incheon, KOR
SCM Lifescience Co Ltd is engaged in the research and development of medicines, hair care medicines, stem cell products in South Korea.

SCM Lifescience Co Headlines

No Headlines